Abstract
Abstract Imaging of the prostate has improved dramatically over the last few decades and has led to the improved detection, staging, and treatment of prostate cancer. Technologies such as multiparametric magnetic resonance imaging (mpMRI) identify three-dimensional regions of interest (ROI) suspicious for prostate cancer, which can then be targeted for biopsy. This is moving us away from the systematic non-targeted biopsies of the past where the entire prostate is sampled. The implementation of this technology has the potential to more accurately stage prostate cancer at the initial diagnosis, therefore pushing men with clinically significant prostate cancer towards earlier treatment and saving men with clinically insignificant cancer from unnecessary tests and treatment. This review will present and discuss the varying techniques for prostate biopsy which implement mpMRI.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
